Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 985.80
+2.50 (0.25%)
Aug 21, 2025, 3:29 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.46M INR
Profits / Employee
1.64M INR
Market Cap
991.95B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
| Aurobindo Pharma | 27,707 |
Zydus Lifesciences News
- 8 days ago - Stocks to watch on brokerages’ radar today, August 13: Minda Corp, Apollo Hospitals, Alkem Labs, Nykaa, Zydus Lifesciences, HAL, ONGC, NHPC, Honasa, Paytm - Business Upturn
- 9 days ago - Zydus Lifesciences Q1 net profit rises 3% to Rs 1,467 crore - The Times of India
- 9 days ago - Zydus Lifesciences Q1 Results: Revenue rises 5.9% YoY to Rs 6,573.7 crore, Net profit up 3.7% YoY - Business Upturn
- 9 days ago - Top Q1 results today, August 12: HAL, ONGC, Hindalco Industries, Zydus Lifesciences, Bharat Dynamics and more to announce earnings - Business Upturn
- 10 days ago - Zydus Lifesciences gets USFDA final approval for Diltiazem Hydrochloride tablets - Business Upturn
- 13 days ago - Zydus Lifesciences gets USFDA nod for Prucalopride tablets, 1 mg and 2 mg - Business Upturn
- 4 weeks ago - Zydus Lifesciences gets tentative approval from USFDA for Ibrutinib tablets - Business Upturn
- 5 weeks ago - Zydus Lifesciences secures USFDA approval for Celecoxib Capsules - Business Upturn